FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605027369> ?p ?o ?g. }

• W2605027369 endingPage "45297" @default.
• W2605027369 startingPage "45286" @default.
• W2605027369 abstract "// Elena Sanmartín 1 , Yania Yáñez 2, 3 , Victoria Fornés-Ferrer 4 , José L. Zugaza 5, 6, 7 , Adela Cañete 2, 3 , Victoria Castel 2, 3 and Jaime Font de Mora 1, 3 1 Laboratory of Cellular and Molecular Biology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain 2 Pediatric Oncology Unit, Hospital Universitario y Politécnico La Fe, València, Spain 3 Precision Oncology Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain 4 Biostatistics Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain 5 Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain 6 Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain 7 IKERBASQUE, Basque Foundation for Science, Bilbao, Spain Correspondence to: Jaime Font de Mora, email: jaime.fontdemora@gmail.com Keywords: neuroblastoma, TIAM1, signaling networks, next generation sequencing Received: June 04, 2016      Accepted: March 17, 2017      Published: April 03, 2017 ABSTRACT Identification of tumor driver mutations is crucial for improving clinical outcome using a personalized approach to the treatment of cancer. Neuroblastoma is a tumor of the peripheral sympathetic nervous system for which only a few driver alterations have been described including MYCN amplification and ALK mutations. We assessed 106 primary neuroblastoma tumors by next generation sequencing using a customized amplicon-based gene panel. Our results reveal that genetic variants in TIAM1 gene associate with better clinical outcome, suggesting a role for these TIAM1 variants in preventing progression of this disease. The detected variants are located within the different domains of TIAM1 that signal to the upstream regulator RAS and downstream effector molecules MYC and RAC, which are all implicated in neuroblastoma etiology and progression. Clinical outcome was improved in tumors where a TIAM1 variant was present concomitantly with either ALK mutation or MYCN amplification. Given the function of these signaling molecules in cell survival, proliferation, differentiation and neurite outgrowth, our data suggest that the TIAM1 -mediated network is essential to neuroblastoma and thus, inhibiting TIAM1 reflects a rational strategy for improving therapy efficacy in neuroblastoma." @default.
• W2605027369 created "2017-04-14" @default.
• W2605027369 creator A5002553674 @default.
• W2605027369 creator A5020502464 @default.
• W2605027369 creator A5054237397 @default.
• W2605027369 creator A5067478190 @default.
• W2605027369 creator A5070867409 @default.
• W2605027369 creator A5075148954 @default.
• W2605027369 creator A5086036956 @default.
• W2605027369 date "2017-04-03" @default.
• W2605027369 modified "2023-09-30" @default.
• W2605027369 title "TIAM1 variants improve clinical outcome in neuroblastoma" @default.
• W2605027369 cites W1500337621 @default.
• W2605027369 cites W1547168939 @default.
• W2605027369 cites W1887383255 @default.
• W2605027369 cites W1965225532 @default.
• W2605027369 cites W1967977447 @default.
• W2605027369 cites W1983551751 @default.
• W2605027369 cites W1987425992 @default.
• W2605027369 cites W1989143807 @default.
• W2605027369 cites W1991008023 @default.
• W2605027369 cites W1994375558 @default.
• W2605027369 cites W1999064468 @default.
• W2605027369 cites W2008620986 @default.
• W2605027369 cites W2015298173 @default.
• W2605027369 cites W2019137723 @default.
• W2605027369 cites W2019528050 @default.
• W2605027369 cites W2021341670 @default.
• W2605027369 cites W2022354436 @default.
• W2605027369 cites W2026449280 @default.
• W2605027369 cites W2035282066 @default.
• W2605027369 cites W2051978340 @default.
• W2605027369 cites W2060275730 @default.
• W2605027369 cites W2067566186 @default.
• W2605027369 cites W2092749728 @default.
• W2605027369 cites W2099536948 @default.
• W2605027369 cites W2099731590 @default.
• W2605027369 cites W2112612051 @default.
• W2605027369 cites W2118071133 @default.
• W2605027369 cites W2122965433 @default.
• W2605027369 cites W2127529738 @default.
• W2605027369 cites W2129963666 @default.
• W2605027369 cites W2132546867 @default.
• W2605027369 cites W2142647163 @default.
• W2605027369 cites W2148502411 @default.
• W2605027369 cites W2152420890 @default.
• W2605027369 cites W2160322808 @default.
• W2605027369 cites W2219761119 @default.
• W2605027369 cites W2330763603 @default.
• W2605027369 cites W2345049328 @default.
• W2605027369 doi "https://doi.org/10.18632/oncotarget.16787" @default.
• W2605027369 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5542186" @default.
• W2605027369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28423360" @default.
• W2605027369 hasPublicationYear "2017" @default.
• W2605027369 type Work @default.
• W2605027369 sameAs 2605027369 @default.
• W2605027369 citedByCount "13" @default.
• W2605027369 countsByYear W26050273692017 @default.
• W2605027369 countsByYear W26050273692018 @default.
• W2605027369 countsByYear W26050273692019 @default.
• W2605027369 countsByYear W26050273692020 @default.
• W2605027369 countsByYear W26050273692021 @default.
• W2605027369 countsByYear W26050273692022 @default.
• W2605027369 countsByYear W26050273692023 @default.
• W2605027369 crossrefType "journal-article" @default.
• W2605027369 hasAuthorship W2605027369A5002553674 @default.
• W2605027369 hasAuthorship W2605027369A5020502464 @default.
• W2605027369 hasAuthorship W2605027369A5054237397 @default.
• W2605027369 hasAuthorship W2605027369A5067478190 @default.
• W2605027369 hasAuthorship W2605027369A5070867409 @default.
• W2605027369 hasAuthorship W2605027369A5075148954 @default.
• W2605027369 hasAuthorship W2605027369A5086036956 @default.
• W2605027369 hasBestOaLocation W26050273691 @default.
• W2605027369 hasConcept C126322002 @default.
• W2605027369 hasConcept C143998085 @default.
• W2605027369 hasConcept C161191863 @default.
• W2605027369 hasConcept C2776715637 @default.
• W2605027369 hasConcept C41008148 @default.
• W2605027369 hasConcept C54355233 @default.
• W2605027369 hasConcept C71924100 @default.
• W2605027369 hasConcept C81885089 @default.
• W2605027369 hasConcept C86803240 @default.
• W2605027369 hasConceptScore W2605027369C126322002 @default.
• W2605027369 hasConceptScore W2605027369C143998085 @default.
• W2605027369 hasConceptScore W2605027369C161191863 @default.
• W2605027369 hasConceptScore W2605027369C2776715637 @default.
• W2605027369 hasConceptScore W2605027369C41008148 @default.
• W2605027369 hasConceptScore W2605027369C54355233 @default.
• W2605027369 hasConceptScore W2605027369C71924100 @default.
• W2605027369 hasConceptScore W2605027369C81885089 @default.
• W2605027369 hasConceptScore W2605027369C86803240 @default.
• W2605027369 hasIssue "28" @default.
• W2605027369 hasLocation W26050273691 @default.
• W2605027369 hasLocation W26050273692 @default.
• W2605027369 hasLocation W26050273693 @default.
• W2605027369 hasLocation W26050273694 @default.
• W2605027369 hasOpenAccess W2605027369 @default.
• W2605027369 hasPrimaryLocation W26050273691 @default.

• next